Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas - PubMed (original) (raw)
Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas
Xiao-Jie Ding et al. Virchows Arch. 2011 May.
Abstract
Chromosomal aberrations in non-small-cell lung carcinomas (NSCLCs) are common events. In our study, the lung cancer cell lines (NCI-H446 and SPC-A-1) displayed numerous numerical and structural alterations in their chromosomes by G-banded karyotypic analysis, and abnormalities of chromosome 12 by fluorescence in situ hybridization. Sequentially, we used 14 microsatellite markers within 12q to analyze loss of heterozygosity (LOH) in lung cancer cell lines and NSCLCs. Possible LOH on 12q were statistically inferred to occur in five lung cell lines. Importantly, 17 out of 25 NSCLCs (68%) showed LOH at chromosome 12q. Frequencies of LOH for individual markers ranged from 18% to 44%. Several deletions which were marked with D12S1301, D12S2196, D12S398, D12S90, D12S1056, D12S1713, D12S375, D12S1040, D12S326, and D12S106 were newly detected. Allelic loss on 12q15-q21 detected with D12S1040 occurred at the later stages of NSCLC progression (p < 0.05, Fisher's exact test). LOH on 12q marked with D12S2196, D12S398, D12S326, and D12S106 were frequently found in NSCLCs from the patients without smoking history (p < 0.05, Fisher's exact test). These findings indicated that allelic loss on 12q is commonly involved in NSCLCs, and new tumor suppressor genes may occur within 12q.
Similar articles
- Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
Grepmeier U, Dietmaier W, Merk J, Wild PJ, Obermann EC, Pfeifer M, Hofstaedter F, Hartmann A, Woenckhaus M. Grepmeier U, et al. Int J Oncol. 2005 Aug;27(2):481-8. Int J Oncol. 2005. PMID: 16010431 - Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.
Pan H, Califano J, Ponte JF, Russo AL, Cheng KH, Thiagalingam A, Nemani P, Sidransky D, Thiagalingam S. Pan H, et al. Cancer Res. 2005 Mar 1;65(5):1664-9. doi: 10.1158/0008-5472.CAN-04-3297. Cancer Res. 2005. PMID: 15753360 - Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: a putative progression model?
El-Naggar AK, Callender D, Coombes MM, Hurr K, Luna MA, Batsakis JG. El-Naggar AK, et al. Genes Chromosomes Cancer. 2000 Feb;27(2):162-8. Genes Chromosomes Cancer. 2000. PMID: 10612804 - Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
Gorgoulis VG, Kotsinas A, Zacharatos P, Mariatos G, Liloglou T, Tsoli E, Kokotas S, Fassoulas C, Field JK, Kittas C. Gorgoulis VG, et al. Cancer. 2000 Nov 1;89(9):1933-45. doi: 10.1002/1097-0142(20001101)89:9<1933::aid-cncr9>3.3.co;2-4. Cancer. 2000. PMID: 11064350 - Molecular genetics of small cell lung carcinoma.
Wistuba II, Gazdar AF, Minna JD. Wistuba II, et al. Semin Oncol. 2001 Apr;28(2 Suppl 4):3-13. Semin Oncol. 2001. PMID: 11479891 Review.
Cited by
- Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung.
Sivakumar S, San Lucas FA, Jakubek YA, McDowell TL, Lang W, Kallsen N, Peyton S, Davies GE, Fukuoka J, Yatabe Y, Zhang J, Futreal PA, Fowler J, Fujimoto J, Ehli EA, Hawk ET, Wistuba II, Kadara H, Scheet P. Sivakumar S, et al. EBioMedicine. 2019 Apr;42:296-303. doi: 10.1016/j.ebiom.2019.03.020. Epub 2019 Mar 21. EBioMedicine. 2019. PMID: 30905849 Free PMC article. - Tubulin alpha-1b chain was identified as a prognosis and immune biomarker in pan-cancer combing with experimental validation in breast cancer.
Wang Y, Li Y, Jing Y, Yang Y, Wang H, Ismtula D, Guo C. Wang Y, et al. Sci Rep. 2024 Apr 8;14(1):8201. doi: 10.1038/s41598-024-58982-z. Sci Rep. 2024. PMID: 38589634 Free PMC article. - The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
Liu M, Zhou K, Huang Y, Cao Y. Liu M, et al. J Exp Clin Cancer Res. 2015 Oct 14;34:121. doi: 10.1186/s13046-015-0235-5. J Exp Clin Cancer Res. 2015. PMID: 26467212 Free PMC article. - Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study.
Czarnecka KH, Migdalska-Sęk M, Antczak A, Pastuszak-Lewandoska D, Kordiak J, Nawrot E, Domańska D, Kaleta D, Górski P, Brzeziańska EB. Czarnecka KH, et al. Mol Biol Rep. 2013 Dec;40(12):6671-84. doi: 10.1007/s11033-013-2782-1. Epub 2013 Oct 4. Mol Biol Rep. 2013. PMID: 24091944 Free PMC article.
References
- Lancet. 1971 Oct 30;2(7731):971-2 - PubMed
- Cancer Res. 1998 Aug 15;58(16):3700-5 - PubMed
- Lung Cancer. 2003 Jan;39(1):23-9 - PubMed
- Lab Invest. 2005 Sep;85(9):1076-85 - PubMed
- Int J Oncol. 2003 Nov;23(5):1357-63 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical